1. Japan Stocks

  2. •

    Industrials

  3. •

    Industrial - Machinery
Nomura Micro Science Co., Ltd.

Nomura Micro Science Co., Ltd.

6254.T
Nomura Micro Science Co., Ltd.JP flagTokyo Stock Exchange
4,220.00
JPY
-170.00
- -
161.58BMarket Cap
Nomura Micro Science Co., Ltd.
6254.T
(Tokyo Stock Exchange)

Recent

price

4,220.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
558.33
428.64
355.88
419.24
340.74
499.88
462.69
597.37
689.53
574.8
825.58
866.51
1,340.11
1,953.85
2,557.88
1,478.41
970.99
Revenue per Share
11.32
4
-2.84
-11.33
-27.68
4.25
19.43
27.77
28.26
34.77
71.2
89.4
156.9
213.47
270.75
100.36
104.27
Basic EPS, GAAP
-1.16
28.36
6.07
-10.7
4.44
-23.54
32.11
-62.95
95.23
-8.84
157.71
20.95
98.75
-508.9
-593.77
78.15
- -
Free Cash Flow per Basic Share
2.01
4.5
3
3.09
2
- -
0.75
3.67
4.98
7.46
8.24
23.67
26.16
42.33
67.17
79.6
- -
Dividend per Share
168.67
171.52
171.32
164.56
135.92
140.29
96
180.33
202.19
228.54
290.54
355.88
484.75
651.1
848.73
861.05
601.24
Book Value per Share
194.97
198.93
208.86
211.05
201.92
195.31
217.66
242.57
261.56
281.28
358.3
428.38
574.68
771.13
979.37
1,045.43
734.9
Tangible Book Value per Share
39
39
37
36
36
36
36
36
36
37
37
37
37
37
38
38
38
Basic Weighted Avg Shares
21,967
16,533
13,288
14,985
12,111
17,768
16,455
21,603
25,132
21,049
30,361
31,901
49,596
73,021
96,360
56,246
36,466
Sales/Revenue/Turnover
4.21
3.62
-2.96
-4.58
-4.54
1.78
4.68
5.74
4.83
8.77
13.09
13.9
13.21
14.58
15.95
11.85
13.51
Operating Margin (%)
320
288
292
345
417
298
225
182
190
179
125
172
191
307
1,653
1,693
- -
Depreciation Expense
445
154
-106
-405
-984
151
691
1,004
1,030
1,273
2,618
3,292
5,807
7,978
10,200
3,818
3,916
Net Income, GAAP
46.65
58.3
363.14
- -
- -
16.68
6.92
11.15
24.86
28.83
27.46
28.11
22.06
26.32
23.88
32.37
14.45
Effective Tax Rate (%)
2.03
0.93
-0.8
-2.7
-8.12
0.85
4.2
4.65
4.1
6.05
8.62
10.32
11.71
10.93
10.58
6.79
10.74
Profit Margin (%)
5,118
5,155
4,837
3,649
3,597
3,493
4,404
4,831
6,469
8,061
10,252
12,641
17,136
24,224
30,096
31,774
20,664
Working Capital
81
65
48
35
16
3
2
45
38
28
16
25
16
8
498
1,616
- -
LT Debt
8,239
8,132
8,122
7,754
7,209
6,963
7,756
8,786
9,548
10,315
13,190
15,932
21,401
28,924
37,014
39,853
27,690
Total Equity
4
2.07
8.71
- -
- -
2.4
6.27
8.16
6.32
9.53
18.8
17.59
22.55
19.93
15.93
4.74
7.78
Return on Invested Capital (%)
4.46
1.75
-2.18
- -
- -
2.08
8.84
10.5
8.94
11.33
21.21
22.77
31.46
24.69
17.66
6.31
9.02
Return on Capital (%)
6.95
2.33
-1.63
-6.59
-18.36
3.08
16.45
20.22
14.83
16.18
27.48
27.67
37.41
37.74
36.23
11.8
17.98
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
22,388
- -
37,028
LT Borrowings
- -
- -
- -
LT Finance Leases
8
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
38
- -
38
Market Capitalization
221,229
162,241
91,110

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
65,505
- -
80,260
Cash, Cash Equivalents & STI
12,142
- -
11,682
Accounts Receivable, Net
8,417
- -
30,582
Inventories
12,615
- -
32,222
Total Current Liabilities
41,281
- -
59,596
Payables & Accruals
- -
- -
- -
ST Debt
22,388
- -
37,028
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
19.51%
25.18%
7.67%
Free Cash Flow
-321.93%
-85.8%
-113.29%
Net Income, GAAP
63.9%
20.96%
-62.57%
Sales/Revenue/Turnover
16.63%
19.62%
-41.63%
Total Cash Common Dividend
2,342.12%
68.36%
19.68%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
12,768
23,788
24,743
11,724
73,021
2025
- -
- -
- -
- -
96,360
2026
- -
- -
- -
- -
56,246

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
30.02
- -
- -
- -
213.47
2025
- -
- -
- -
- -
270.75
2026
- -
- -
- -
- -
100.36

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
42.33
2025
- -
- -
- -
- -
67.17
2026
- -
- -
- -
- -
79.6
Similar Companies
Azorean Aquatic Technologies, S.A. (MLAAT.PA)
Mantex AB (publ) (MANTEX.ST)
Fujitec Co., Ltd. (6406.T)
JE Cleantech Holdings Limited (JCSE)
Dalian Huarui Heavy Industry Group Co., Ltd. (002204.SZ)
Ruichang Intl (1334.HK)
Business
Nomura Micro Science Co., Ltd. (6254.T) designs, manufactures, installs, sells, and maintains advanced water treatment systems, including ultrapure water production systems for the electronics and high-precision device industries; pharmaceutical water production systems, pure steam generators for sterilization, package-type purified water systems, and membrane-based water for injection (WFI) production systems; wastewater treatment and water reclamation systems; and related functional products such as pretreatment membrane systems (FINESEP NFS Series), heat regenerative membrane filtration equipment (HEATMASTER HM Series), electrodeionization (EDI) systems, high-efficiency reverse osmosis systems (HERO), high-efficiency vacuum degasifiers (HE-VDG), membrane degasifiers, ozone water production systems (NOMUREXON O3), hydrogen water production systems (NOMUREXON H2), anti-static equipment (Super Bubbler WAC), return contamination monitors (RC Monitor), H2O2 monitors for ultrapure water (NOXiEMON), Nuclepore membranes, filter cartridges (NOMULITE), piping and environmental materials, and on-site pure water supply services. Founded in 1969 and headquartered at 2-9-10 Okata, Atsugi-shi, Kanagawa-ken, Japan, the company operates primarily in Japan, with subsidiaries and activities spanning South Korea (Nomura Micro Science Korea Co., Ltd.), the United States (Nomura Micro Science USA Ltd., Co.), Taiwan (Nomura Micro Science Engineering Co., Ltd.), China (Shanghai Nomura Engineering Co., Ltd.), Singapore (Nomura Micro Science Singapore Pte. Ltd.), and other Asian markets, serving electronics, pharmaceuticals, biotechnology, food, plants, environmental energy, and analysis industries. Recent developments include Shanghai Nomura Engineering Co., Ltd. absorbing Nomura Shanghai Engineering Technology Co., Ltd. as the surviving entity in 2025; establishment of Nomura Micro Science Singapore Pte. Ltd. in 2024 to bolster Southeast Asia sales; acquisition of full equity in Hydrofoil (Shanghai) Engineering Co., Ltd. (renamed Nomura Shanghai Engineering Technology Co., Ltd.) in 2023; record FY2025 financial performance driven by major water treatment projects in the United States and South Korea, alongside new orders in India (TATA project); and strategic initiatives such as global sales expansion, engineering process reforms including skid mounting and piping prefabrication, accelerated R&D under the SMART UP3 program for next-generation ultrapure water and environmental systems, and growing sales of WFI manufacturing systems with endotoxin monitoring development.